Literature DB >> 14532999

Differential expression of homing receptor CD103 on lamina propria lymphocytes and association of CD103 with epithelial adhesion molecules in inflammatory bowel disease.

Nobuhide Oshitani1, Kenji Watanabe, Kiyoshi Maeda, Yasuhiro Fujiwara, Kazuhide Higuchi, Takayuki Matsumoto, Tetsuo Arakawa.   

Abstract

Intraepithelial lymphocytes play an important role in mucosal immunology, and are involved in the pathogenesis of inflammatory bowel disease. We studied expression of CD103 on mucosal lymphocytes with epithelial adhesion molecules in patients with inflammatory bowel disease. Surgical specimens of human colon were obtained from 12 patients with ulcerative colitis, 12 patients with Crohn's disease, and 5 controls. Frozen sections were cut and expression of CD103 on lymphocytes, E-cadherin, CD44V3, and CD44v6 on intestinal epithelium was studied. Frequency of CD103-positive intraepithelial lymphocytes did not differ among controls, patients with ulcerative colitis, and patients with Crohn's disease. The frequency of CD103-positive lamina propria lymphocytes was significantly higher in patients with Crohn's disease than in controls and patients with ulcerative colitis. The frequency of CD103-positive intraepithelial lymphocytes was significantly correlated with that of lamina propria lymphocytes in patients with ulcerative colitis. The frequency of CD103-positive intraepithelial lymphocytes was significantly correlated with epithelial E-cadherin expression but that of lamina propria lymphocytes was not. Differential up-regulation of CD103 expression on lamina propria lymphocytes in Crohn's disease may indicate differential humoral or cellular regulation in inducing CD103 molecules on lymphocytes in patients with this disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14532999

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  10 in total

Review 1.  Can We Target Endogenous Anti-inflammatory Responses as a Therapeutic Strategy for Inflammatory Bowel Disease?

Authors:  Ross John Porter; Caroline Andrews; Daniel Paul Brice; Scott Kenneth Durum; Mairi Hall McLean
Journal:  Inflamm Bowel Dis       Date:  2018-09-15       Impact factor: 5.325

2.  Rheostat regulation of integrin-mediated leukocyte adhesion.

Authors:  Ivor S Douglas; Themistocles Dassopoulos
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 3.  Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease.

Authors:  Emilio G Quetglas; Zlatan Mujagic; Simone Wigge; Daniel Keszthelyi; Sebastian Wachten; Ad Masclee; Walter Reinisch
Journal:  World J Gastroenterol       Date:  2015-11-28       Impact factor: 5.742

4.  Inherent Immune Cell Variation Within Colonic Segments Presents Challenges for Clinical Trial Design.

Authors:  Christopher J Tyler; Mauricio Guzman; Luke R Lundborg; Shaila Yeasmin; Tamara Perez-Jeldres; Andres Yarur; Brian Behm; Parambir S Dulai; Derek Patel; Giorgos Bamias; Jesús Rivera-Nieves
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 9.071

Review 5.  Integrin antagonists as potential therapeutic options for the treatment of Crohn's disease.

Authors:  Leon P McLean; Raymond K Cross
Journal:  Expert Opin Investig Drugs       Date:  2016       Impact factor: 6.206

6.  A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis.

Authors:  Paul J Rutgeerts; Richard N Fedorak; Daan W Hommes; Andreas Sturm; Daniel C Baumgart; Brian Bressler; Stefan Schreiber; John C Mansfield; Marna Williams; Meina Tang; Jennifer Visich; Xiaohui Wei; Mary Keir; Diana Luca; Dimitri Danilenko; Jackson Egen; Sharon O'Byrne
Journal:  Gut       Date:  2012-06-20       Impact factor: 23.059

Review 7.  The Emerging Role of CD8+ Tissue Resident Memory T (TRM) Cells in Antitumor Immunity: A Unique Functional Contribution of the CD103 Integrin.

Authors:  Stéphanie Corgnac; Marie Boutet; Maria Kfoury; Charles Naltet; Fathia Mami-Chouaib
Journal:  Front Immunol       Date:  2018-08-15       Impact factor: 7.561

8.  AlphaE Integrin Expression Is Increased in the Ileum Relative to the Colon and Unaffected by Inflammation.

Authors:  Ryan Ichikawa; Christopher A Lamb; Jeff Eastham-Anderson; Alexis Scherl; Laura Raffals; William A Faubion; Miriam R Bennett; Anna K Long; John C Mansfield; John A Kirby; Mary E Keir
Journal:  J Crohns Colitis       Date:  2018-11-09       Impact factor: 9.071

9.  Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.

Authors:  Britt Roosenboom; Peter J Wahab; Carolijn Smids; Marcel J M Groenen; Elly van Koolwijk; Ellen G van Lochem; Carmen S Horjus Talabur Horje
Journal:  Inflamm Bowel Dis       Date:  2019-08-20       Impact factor: 5.325

Review 10.  Functional Heterogeneity and Therapeutic Targeting of Tissue-Resident Memory T Cells.

Authors:  Esmé T I van der Gracht; Felix M Behr; Ramon Arens
Journal:  Cells       Date:  2021-01-15       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.